Universal Biosensors, Inc. (ASX:UBI)
Australia · Delayed Price · Currency is AUD 0.0220
-0.0020 (-8.33%)
Aug 1, 2025, 3:31 PM AEST
Model N Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 6.37 | 6.28 | 6.63 | 4.52 | 5.78 | 3.2 | Upgrade | |
Revenue Growth (YoY) | -6.45% | -5.28% | 46.58% | -21.68% | 80.41% | -53.57% | Upgrade |
Cost of Revenue | 2.4 | 2.28 | 2.35 | 2.39 | 3.67 | 2.58 | Upgrade |
Gross Profit | 3.97 | 4 | 4.28 | 2.14 | 2.11 | 0.62 | Upgrade |
Selling, General & Admin | 16.34 | 16.03 | 15.17 | 11.35 | 6.05 | 6.42 | Upgrade |
Research & Development | 4.71 | 4.13 | 4.84 | 12.02 | 8.92 | 4.53 | Upgrade |
Operating Expenses | 21.75 | 20.97 | 20.97 | 26.02 | 17.14 | 13.18 | Upgrade |
Operating Income | -17.78 | -16.97 | -16.68 | -23.88 | -15.04 | -12.56 | Upgrade |
Interest Expense | -0.02 | -0.02 | -0.02 | -0.02 | - | - | Upgrade |
Interest & Investment Income | 0.44 | 0.45 | 0.73 | 0.38 | 0.05 | 0.29 | Upgrade |
Currency Exchange Gain (Loss) | 0.14 | -0.01 | -0.03 | -0.12 | 0.27 | -0.17 | Upgrade |
Other Non Operating Income (Expenses) | 2.57 | 2.31 | 9.23 | 4.74 | 4.05 | 2.86 | Upgrade |
EBT Excluding Unusual Items | -14.64 | -14.24 | -6.76 | -18.89 | -10.66 | -9.58 | Upgrade |
Asset Writedown | - | - | - | -11.01 | - | - | Upgrade |
Other Unusual Items | - | - | 0.02 | - | 0.15 | 1.27 | Upgrade |
Pretax Income | -14.64 | -14.24 | -6.74 | -29.91 | -10.51 | -7.64 | Upgrade |
Income Tax Expense | - | - | - | -3.05 | - | - | Upgrade |
Net Income | -14.64 | -14.24 | -6.74 | -26.85 | -10.51 | -7.64 | Upgrade |
Net Income to Common | -14.64 | -14.24 | -6.74 | -26.85 | -10.51 | -7.64 | Upgrade |
Shares Outstanding (Basic) | 291 | 270 | 212 | 199 | 178 | 178 | Upgrade |
Shares Outstanding (Diluted) | 291 | 270 | 212 | 199 | 178 | 178 | Upgrade |
Shares Change (YoY) | 36.99% | 27.32% | 6.87% | 11.82% | 0.08% | 0.05% | Upgrade |
EPS (Basic) | -0.05 | -0.05 | -0.03 | -0.14 | -0.06 | -0.04 | Upgrade |
EPS (Diluted) | -0.05 | -0.05 | -0.03 | -0.14 | -0.06 | -0.04 | Upgrade |
Free Cash Flow | -10.64 | -12.71 | -16.09 | -16.27 | -10.56 | -8.68 | Upgrade |
Free Cash Flow Per Share | -0.04 | -0.05 | -0.08 | -0.08 | -0.06 | -0.05 | Upgrade |
Gross Margin | 62.31% | 63.70% | 64.60% | 47.27% | 36.45% | 19.46% | Upgrade |
Operating Margin | -279.24% | -270.08% | -251.48% | -527.72% | -260.28% | -392.12% | Upgrade |
Profit Margin | -229.89% | -226.65% | -101.64% | -593.48% | -181.85% | -238.49% | Upgrade |
Free Cash Flow Margin | -167.16% | -202.35% | -242.62% | -359.50% | -182.79% | -270.97% | Upgrade |
EBITDA | -17.07 | -16.17 | -15.71 | -21.09 | -12.47 | -10.13 | Upgrade |
EBITDA Margin | -268.03% | -257.30% | -236.86% | - | -215.85% | - | Upgrade |
D&A For EBITDA | 0.71 | 0.8 | 0.97 | 2.79 | 2.57 | 2.43 | Upgrade |
EBIT | -17.78 | -16.97 | -16.68 | -23.88 | -15.04 | -12.56 | Upgrade |
EBIT Margin | -279.24% | -270.08% | -251.48% | - | -260.28% | - | Upgrade |
Revenue as Reported | 6.37 | 6.28 | 6.63 | 4.52 | 5.78 | 3.2 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.